Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Theta and Alpha Frequency-Tuned Meditation on Negative Symptoms in Schizophrenia: A Randomized Controlled Trial

NCT07437365 is registered in ClinicalTrials.gov with Psychiatric Hospital of the Cross as lead sponsor.

NCT NCT07437365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07437365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Theta and Alpha Frequency-Tuned Meditation on Negative Symptoms in Schizophrenia: A Randomized Controlled Trial
Lead sponsor
Psychiatric Hospital of the Cross
Phase
Not applicable
Overall status
Completed
Start date
August 5, 2025
Completion date
October 31, 2025
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophenia disorder